A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles